These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 477630)

  • 1. An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats.
    Turkanis SA; Smiley KA; Borys HK; Olsen DM; Karler R
    Epilepsia; 1979 Aug; 20(4):351-63. PubMed ID: 477630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.
    Chiu P; Olsen DM; Borys HK; Karler R; Turkanis SA
    Epilepsia; 1979 Aug; 20(4):365-75. PubMed ID: 113206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
    Turkanis SA; Karler R
    Psychopharmacology (Berl); 1981; 75(3):294-8. PubMed ID: 6275447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
    Consroe P; Wolkin A
    J Pharmacol Exp Ther; 1977 Apr; 201(1):26-32. PubMed ID: 850145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cannabinoids as potential antiepileptics.
    Karler R; Turkanis SA
    J Clin Pharmacol; 1981; 21(S1):437S-448S. PubMed ID: 6975285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
    Colasanti BK; Lindamood C; Craig CR
    Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials.
    Turkanis SA; Chiu P; Borys HK; Karler R
    Psychopharmacology (Berl); 1977 Apr; 52(2):207-12. PubMed ID: 407606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
    Karler R; Turkanis SA
    Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiseizure effects of the cannabinoids in the amygdala-kindling model.
    Fallah MS; Dlugosz L; Scott BW; Thompson MD; Burnham WM
    Epilepsia; 2021 Sep; 62(9):2274-2282. PubMed ID: 34251027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
    Zuardi AW; Teixeira NA; Karniol IC
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of 22-day treatment on the anticonvulsant properties of cannabinoids.
    Karler R; Borys HK; Turkanis SA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):105-9. PubMed ID: 6289137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy.
    Borowicz KK; Luszczki JJ; Duda AM; Czuczwar SJ
    Epilepsia; 2003 May; 44(5):640-6. PubMed ID: 12752462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ
    Javadzadeh Y; Santos A; Aquilino MS; Mylvaganam S; Urban K; Carlen PL
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between cannabidiol and Δ
    Anderson LL; Low IK; McGregor IS; Arnold JC
    Br J Pharmacol; 2020 Sep; 177(18):4261-4274. PubMed ID: 32608111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.
    Mascal M; Hafezi N; Wang D; Hu Y; Serra G; Dallas ML; Spencer JPE
    Sci Rep; 2019 May; 9(1):7778. PubMed ID: 31123271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats.
    Turkanis SA; Karler R
    Neuropharmacology; 1982 Jan; 21(1):7-13. PubMed ID: 6278353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic potential of cannabidiol analogs.
    Consroe P; Martin A; Singh V
    J Clin Pharmacol; 1981; 21(S1):428S-436S. PubMed ID: 7298873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
    Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.